Market Tracker

03/31 12:50pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.06
Delayed Data
As of 12:31pm ET
 +0.03 / +2.91%
Today’s Change
0.73
Today|||52-Week Range
1.66
+7.17%
Year-to-Date

Today’s Trading

Previous close1.03
Today’s open1.03
Day’s range1.03 - 1.08
Volume38,934
Average volume (3 months)175,781
Market cap$45.5M
Dividend yield--
Data as of 12:31pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.6
Price/Sales1.47
Price/Book8.64

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.04-1.48%
PTNPalatin Technologies...-0.02-1.92%
HEBHemispherx Biopharma...-0.01-2.27%
IMNPImmune Pharmaceutica...-0.10-5.28%
Data as of 12:34pm ET, 03/31/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts